Country
Full text data for US and EP
Status
Type
Filing Date
Publication Date
Inventor
Assignee
Click to expand
IPC
No.
Publication Number
Title
Publication/Patent Number Publication/Patent Number
Publication date Publication date
Application number Application number
Filing date Filing date
Inventor Inventor
Assignee Assignee
IPC IPC
1
UA38369U
Publication/Patent Number: UA38369U
Publication date: 2009-01-12
Application number: 2008011381
Filing date: 2008-09-22
Abstract: A method for treating the patients with gastrointestinal cancer with metastases into the liver comprises intra-arterial chemotherapy (into the proper hepatic artery). Prior to the endovascular treatment and after the first course of chemotherapy
2
UA42669U
Publication/Patent Number: UA42669U
Publication date: 2009-07-10
Application number: 200902720
Filing date: 2009-03-24
Abstract: A method for predicting the efficacy of chemotherapy in the patients with breast cancer comprises the radiological examination. The mammoscintigraphy performed prior to chemotherapy allows for estimating the rate of radiopharmaceutical elimination from the tissue of breast cancer. When the rate exceeds the threshold value A method for predicting the efficacy of chemotherapy in the patients with breast cancer comprises the radiological examination. The mammoscintigraphy performed prior to chemotherapy allows for estimating the rate of radiopharmaceutical elimination from the tissue of breast ...more ...less
3
UA42672U
Publication/Patent Number: UA42672U
Publication date: 2009-07-10
Application number: 200902946
Filing date: 2009-03-30
Abstract: A method for neoadjuvant intra-arterial chemotherapy in the treatment of the locally advanced cancer of the tongue relates to medicine
4
UA42622U
Publication/Patent Number: UA42622U
Publication date: 2009-07-10
Application number: 200902055
Filing date: 2009-03-10
Abstract: Method for control of specific cell response on tumor antigen in patients with malignant new growths includes determination of cytokine profile of lymphocytes after sub-cultivation with tumor antigen. Investigations are carried out after each of four introductions of anti-tumor vaccine and at simultaneous reveal of decrease of secretion of interleukin -4 and increase of interferonin lymphocytes under effect of autologous tumor antigen one predicts positive response on anti-tumor vaccination carried out. Method for control of specific cell response on tumor antigen in patients with malignant new growths includes determination of cytokine profile of lymphocytes after sub-cultivation with tumor antigen. Investigations are carried out after each of four introductions of anti-tumor ...more ...less
5
UA44239U
Publication/Patent Number: UA44239U
Publication date: 2009-09-25
Application number: 200903998
Filing date: 2009-04-23
Abstract: Method for prediction of early metastasis of osteogenous sarcoma includes definition of protein agents level defining. The black blood serum is used as the test material
6
UA39714U
Publication/Patent Number: UA39714U
Publication date: 2009-03-10
Application number: 200811614
Filing date: 2008-09-29
Abstract: Method for evaluation of formation of specific cellular response in oncological patients after implementation of dendritocellular vaccine therapy includes determination of percentage of retardation of migration of leucocytes of peripheral blood by means of polyclonal activator of phytohemagliutin as positive control. Additionally one uses autolytic tumor antigene with which dendrite cells are loaded. At increase of percentage of retardation of migration of leucocytes compared to control values one determines presence of formation of specific cell response with prediction of positive response to vaccine therapy. Method for evaluation of formation of specific cellular response in oncological patients after implementation of dendritocellular vaccine therapy includes determination of percentage of retardation of migration of leucocytes of peripheral blood by means of polyclonal activator ...more ...less
7
UA43727U
Publication/Patent Number: UA43727U
Publication date: 2009-08-25
Application number: 200903729
Filing date: 2009-04-16
Abstract: A method for preventing metastasizing comprises the use of tumor-specific transfer factor obtained from lymphocytes sensitized in vivo to the tumor antigens at the peak of the immune response of the rats after intraperitoneal immunization with the live cells of Lewis lung carcinoma. A method for preventing metastasizing comprises the use of tumor-specific transfer factor obtained from lymphocytes sensitized in vivo to the tumor antigens at the peak of the immune response of the rats after intraperitoneal immunization with the live cells of Lewis lung ...more ...less
8
UA44240U
Publication/Patent Number: UA44240U
Publication date: 2009-09-25
Application number: 200903999
Filing date: 2009-04-23
Abstract: A method for treatment of patients with the osteosarcoma comprises neoadjuvant intravascular polychemotherapy. The chemopreparations together with the COX-2 inhibitir Dinastatum are administered intra-arterialy.
9
UA43728U
Publication/Patent Number: UA43728U
Publication date: 2009-08-25
Application number: 200903731
Filing date: 2009-04-16
Abstract: A method for producing transfer factor specific to the cells of the xenogenic tumor comprises the use of low-molecular extract of the splenocytes. The rats are immunized with the live cells of Lewis lung carcinoma intraperitoneally. The preparation of transfer factor is obtained on Day 14. A method for producing transfer factor specific to the cells of the xenogenic tumor comprises the use of low-molecular extract of the splenocytes. The rats are immunized with the live cells of Lewis lung carcinoma intraperitoneally. The preparation of transfer factor is obtained ...more ...less
10
UA84618C2
Publication/Patent Number: UA84618C2
Publication date: 2008-11-10
Application number: 2006013848
Filing date: 2006-12-26
Abstract: The invention relates to medicine
11
UA37073U
Publication/Patent Number: UA37073U
Publication date: 2008-11-10
Application number: 200809284
Filing date: 2008-07-16
Abstract: A method for predicting the course of the disease in the patients with gastric cancer comprises immunohistochemical assessment of E-cadherin and β-catenin in the deparaffinized section of cancer samples. The positive reaction with the monoclonals against р53